Opus Genetics financials
$4.96−1.88%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 |
|---|---|---|---|---|---|---|---|
| Revenue | $755.0K | $2.2M | $3.9M | $3.1M | $2.9M | $4.4M | $4.3M |
| Gross profit | $755.0K | $2.2M | $3.9M | $3.1M | $2.9M | $4.4M | $4.3M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | -$16.5M | -$14.4M | -$11.5M | -$8.3M | -$8.9M | -$9.9M | -$38.0M |
| Net income | -$8.1M | -$65.5M | -$16.5M | -$17.5M | -$7.4M | -$8.2M | -$35.1M |
| Net margin | −1072.6% | −3038.2% | −427.5% | −566.9% | −257.5% | −187.5% | −816.7% |
| Diluted EPS | $-0.14 | $-0.75 | $-0.20 | $-0.25 | $-0.12 | $-0.24 | $-1.16 |
| EBITDA | -$16.5M | -$14.4M | -$11.4M | -$8.3M | -$8.9M | -$9.9M | -$38.0M |
| Operating cash flow | -$11.9M | -$12.7M | -$9.8M | -$6.2M | -$10.3M | -$9.0M | -$7.4M |
| Free cash flow | -$11.9M | -$12.7M | -$9.8M | -$6.2M | -$10.3M | -$9.0M | -$7.4M |
| Diluted shares | 111.4M | 86.9M | 81.0M | 70.6M | 63.4M | 33.9M | 30.4M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $88.8M | $60.0M | $45.1M | $30.8M | $32.4M | $41.8M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.0K |
| Total debt | $34.9M | $1.2M | $0.00 | $1.1M | $1.0M | $0.00 |
| Total assets | $93.0M | $66.8M | $50.2M | $36.1M | $38.7M | $48.2M |
| Total liabilities | $106.0M | $87.9M | $34.9M | $30.2M | $21.2M | $24.3M |
| Shareholders' equity | -$13.0M | -$45.8M | $15.3M | $6.0M | $17.5M | $5.1M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology